MANGOCEUTICALS, INC. (MGRX) — Institutional Holders, Q2 2026
18 institutional investment managers reported a MGRX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $455.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
MGRX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSNew · +338,964 sh+$128.8K
- XTX Topco LtdAdded · +173,114 sh+$65.8K
- HRT FINANCIALNew · +36,003 sh+$13.7K
- ACT AdvisorsNew · +26,863 sh+$10.2K
- AMERIFLEX GROUPNew · +2,885 sh+$1.1K
Biggest sellers
- JANE STREET GROUPSold out · -72,746 sh-$27.6K
- Virtu FinancialSold out · -61,028 sh-$23.2K
- GEODE CAPITAL MANAGEMENTTrimmed · -38,239 sh-$14.5K
- StoneX GroupSold out · -16,039 sh-$6.1K
- OSAICSold out · -3,285 sh-$1.2K
MGRX 13F holders ranked 1–18 of 18
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS#1 · 338,964 sh | 338,964 | $128.8K | 0.00% | New |
| 2 | XTX Topco Ltd#2 · 186,256 sh | 186,256 | $70.8K | <0.01% | +1317.3% |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 156,243 sh | 156,243 | $59.4K | 0.00% | -19.7% |
| 4 | Ikarian Capital#4 · 138,146 sh | 138,146 | $52.5K | <0.01% | 0.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT#5 · 123,041 sh | 123,041 | $46.8K | 0.00% | 0.0% |
| 6 | VANGUARD FIDUCIARY#6 · 57,163 sh | 57,163 | $21.7K | 0.00% | 0.0% |
| 7 | BOOTHBAY FUND MANAGEMENT#7 · 38,441 sh | 38,441 | $14.6K | <0.01% | 0.0% |
| 8 | NORTHERN#8 · 37,579 sh | 37,579 | $14.3K | 0.00% | 0.0% |
| 9 | Ackerman Capital Advisors#9 · 34,500 sh | 34,500 | $13.1K | <0.01% | 0.0% |
| 10 | HRT FINANCIAL#10 · 36,003 sh | 36,003 | $13.0K | 0.00% | New |
| 11 | ACT Advisors#11 · 26,863 sh | 26,863 | $10.2K | — | New |
| 12 | GOLDMAN SACHS GROUP#12 · 11,589 sh | 11,589 | $4.4K | 0.00% | -1.4% |
| 13 | Csenge Advisory Group#13 · 10,000 sh | 10,000 | $3.8K | <0.01% | 0.0% |
| 14 | AMERIFLEX GROUP#14 · 2,885 sh | 2,885 | $1.1K | <0.01% | New |
| 15 | Fortitude Family Office#15 · 1,343 sh | 1,343 | $510.00 | — | 0.0% |
| 16 | MORGAN STANLEY#16 · 1,000 sh | 1,000 | $380.00 | 0.00% | 0.0% |
| 17 | Tower Research Capital (TRC)#17 · 783 sh | 783 | $298.00 | 0.00% | -0.3% |
| 18 | BARCLAYS PLC#18 · 5 sh | 5 | $2.00 | 0.00% | New |
Funds that sold out of MGRX in Q2 2026 (4)
Held MGRX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| JANE STREET GROUP72,746 sh | 72,746 | $26.2K |
| Virtu Financial61,028 sh | 61,028 | $22.0K |
| StoneX Group16,039 sh | 16,039 | $5.8K |
| OSAIC3,285 sh | 3,285 | $1.2K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.